Vaccines for Immune-Mediated Diseases

Patients with safe interceded incendiary ailments (IMID, for instance, RA, IBD or skin problem, square measure at increased danger of contamination, partially in light-weight of the malady itself, but for the foremost half in light-weight of treatment with immune modulatory or immunological disorder medications. in spite of their raised hazard for immunisation preventable upset, the immunisation scope in IMID patients is shockingly low.

    Related Conference of Vaccines for Immune-Mediated Diseases

    February 08-09, 2024

    4th International Conference on Vaccine Research

    Madrid, Spain
    May 30-31, 2024

    World congress on Immunology and Virology Diseases

    Vienna, Austria

    Vaccines for Immune-Mediated Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in